Primagen Holding

Primagen Holding B.V. devel­ops mol­e­c­u­lar tests for diag­nos­ing and mon­i­tor­ing cer­tain forms of can­cer.

Current prod­uct devel­op­ment stage: pre­clin­i­cal.